5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 2 / Phase 32026-07-17NCT02416388
Glofitamab in Real Lifelarge B-cell lymphomaRecruitingNot stated2026-06-03NCT06994169
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)Hematopathology Eligible or CAR-t Cell TreatmentRecruitingNot stated2026-03-04NCT04328298
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First LineFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderActive, not recruitingPhase 32025-12-04NCT05201547
Transplantation After Complete Response In Patients With T-cell LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasmRecruitingNot applicable2023-09-28NCT05444712